Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.141 USD | +6.98% | +7.31% | -30.88% |
Sales 2024 * | 14.8M 20.21M | Sales 2025 * | 19.28M 26.34M | Capitalization | 5.08M 6.94M |
---|---|---|---|---|---|
Net income 2024 * | -3M -4.1M | Net income 2025 * | - 0 | EV / Sales 2024 * | 0.34 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
5.64
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on NovaBay Pharmaceuticals, Inc.
1 day | +6.98% | ||
1 week | +7.31% | ||
Current month | +74.50% | ||
1 month | +78.93% | ||
3 months | -8.50% | ||
6 months | -52.67% | ||
Current year | -30.88% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.141 | +6.98% | 9,375,236 |
24-05-24 | 0.1318 | -5.86% | 9,768,666 |
24-05-23 | 0.14 | +0.14% | 12,733,563 |
24-05-22 | 0.1398 | +6.39% | 10,923,078 |
24-05-21 | 0.1314 | -24.66% | 20,243,372 |
Delayed Quote Nyse, May 28, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.88% | 5.08M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.21% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- NBY Stock